Pharmaceutical Headlines for 20 may 2011 ( Friday ) !

Pharmaceutical Headlines for 20 may 2011 ( Friday ) !

AstraZeneca PLC (AZN) Chops Jobs in Massachusetts More...

Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Destroyed Shareholder Value More Than Any Drugmaker More...


AstraZeneca PLC (AZN) Rumored to be Eyeing Up US Target, Analysts Believe Cubist Pharmaceuticals, Inc. (CBST) to be a Possibility More...


Ridgemont Equity Takes Majority Stake In Gallus Biopharmaceuticals LLC More...

Pfizer Inc. (PFE) Pays $7.5 Million Regulatory Milestone to Auxilium Pharmaceuticals (AUXL) More...


Baylor College of Medicine and Golden Helix Collaborate to Put Better Rare Variant Analysis into the Hands of Researchers More...


Logos Technologies Joins Medidata Solutions, Inc. Technology Partner Program More...


ASKA Pharmaceutical and HRA Pharma Announce Exclusive Licensing Agreement for Ulipristal Acetate to Treat Uterine Fibroids in Japan More...


Titertek Instruments, Inc. and Berthold Technologies Have Joined Forces More...

EMD Serono, Inc. (Rockland) President and CEO Fereydoun Firouz Resigns More...


Geron Corporation (GERN) Promotes, Adds to Executive Team More...


• Board Evolution at BioAlliance to Support Its Growth Strategy More...


MorphoSys AG Announces Re-election of Two Supervisory Board Members More...


• Shareholders OctoPlus Appoint Jan Egberts to Executive Board More...


China Ruitai International Holdings Co., Ltd. Reports First Quarter 2011 Results More...


Cyclodextrin Technologies Development, Inc. (CTDI) Reports Record 1st Quarter 2011 Sales More...


Neuland Labs Reports Financial Results for Fiscal Year 2011 More...


Tibet Pharmaceuticals Announces Availability of First Quarter 2011 Earnings Call Transcript More...

• FDA Approves Tibotec's HIV Drug Edurant More...

Pfizer Inc. (PFE): ELIQUIS(R) (apixaban) Approved In Europe For Preventing Venous Thromboembolism After Elective Hip Or Knee Replacement More...

American Regent, Inc. Initiates Nationwide Voluntary Recall of Sterile Water for Injection, USP, 50 mL Single Dose Vial Due to Particulate Matter More...

• CHMP Issues Positive Opinion for Merck & Co., Inc. (MRK)'s VICTRELISTM (boceprevir), Oral Hepatitis C Virus (HCV) Protease Inhibitor More...

Amgen (AMGN) Receives CHMP Positive Opinion for XGEVA(TM) (Denosumab) in the European Union More...

Biogen Idec, Inc. (Massachusetts) (BIIB): European Medicines Agency's Committee for Medicinal Products for Human Use Issues Positive Opinion on Marketing Authorization Application for FAMPYRA More...


Acorda Therapeutics (ACOR) Statement on CHMP Positive Opinion on Marketing Authorization Application for FAMPYRA(R) in Europe More...

INSYS Therapeutics Announces NDA PDUFA Date for Fentanyl SL SprayMore...

• FDA Panel Calls for New Trial on Abbott Laboratories (ABT)'s Trilipix More...

Progenics Pharmaceuticals, Inc. (PGNX) Announces Results of Methylnaltrexone Phase 3 Safety Study in Chronic, Non-Malignant Pain PatientsMore...

Onyx Pharmaceuticals, Inc. (ONXX) Announces Updated Pivotal Carfilzomib Phase 2B Data More...

Medivir AB (MVIRb.F) Announces Positive 48-week Interim Data from TMC435 Hepatitis C Phase 2b ASPIRE Study in Treatment-Experienced Genotype-1 Patients More...

• Viagra Could Reduce Multiple Sclerosis Symptoms, Autonoma de Barcelona Study More...

• Supplements 'Reduce Risk of Pre-Eclampsia' - Universidad Nacional Study More...

• New Drug Targets for Squamous Cell Carcinoma, Fred Hutchinson Cancer Research Center Study More...

• U.S. Navy Doctor's Drug Study Under Scrutiny More...

• Study Finds 10% of Cancer Patients Abandon Oral Anti-Cancer Medications,Avalere Health Study Finds More...


( Source: Biospace )
Tags: ,

About author

Make it happen !!

0 comments

Leave a Reply